 I'm Nicole Murray with your Money Now. Pfizer appears to be on its way towards stabilizing its business and winning back Wall Street's favor after the sudden decline of its COVID business. But the company is struggling to balance that with the concerns and fears of its workers. CNBC spoke about the dizzying climb of Pfizer's business, its rapid decline in turnaround strategy with 11 current and former employees, all of whom asked to remain anonymous for fear of retaliation and expressed concern.